Rapt Therapeutics
company
Funding Round
Post-IPO Equity
Money Raised
$ 143.70M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 1, 2020 | Post-IPO Equity | 0 | Solasta Ventures | Detail |
| Apr 26, 2016 | Series B | $ 50M | Celgene,Kleiner Perkins,etc. | Detail |
| Jun 19, 2019 | Series C | $ 37M | Kleiner Perkins,Regents of the University of California,etc. | Detail |
| Aug 31, 2015 | Series A | $ 29M | Detail | |
| Dec 21, 2017 | Series C | $ 60M | Celgene,GV,etc. | Detail |
| Oct 30, 2019 | IPO | $ 36M | Detail |
